Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model
Carla P. M. Molthoff, Herbert M. Pinedo, Hennie M. M. Schlüper, Epie BovenVolume:
50
Year:
1992
Language:
english
Pages:
7
DOI:
10.1002/ijc.2910500324
File:
PDF, 1.12 MB
english, 1992